<i>O</i>-マンノシル型糖鎖とその異常による先天性筋ジストロフィー

DOI Web Site Web Site PubMed 被引用文献2件 参考文献69件
  • 遠藤 玉夫
    <i>(財)東京都高齢者研究・福祉振興財団東京都老人総合研究所糖蛋白質研究グループ</i>

書誌事項

タイトル別名
  • Finding of <i>O</i>-mannosyl Glycan in Mammals and Congenital Muscular Dystrophies due to Glycosylation Defects
  • O-マンノシル型糖鎖とその異常による先天性筋ジストロフィー
  • O マンノシルガタ トウサ ト ソノ イジョウ ニ ヨル センテンセイ キンジストロフィー

この論文をさがす

抄録

Most proteins within living organisms contain glycans. Glycan structures can modulate the biological properties and function of glycoproteins. Developments in glycobiology have revealed a new type of glycosidic linkage to the peptide portion, the O-mannosyl linkage in mammals, although heretofore it had been thought to be specific to yeast. One of the best known O-mannosyl-modified glycoproteins is dystroglycan, which is a central component of dystrophin-glycoprotein complex isolated from skeletal muscle membranes. We identify and characterize a glycosyltransferase, UDP-N-acetylglucosamine: protein O-mannose β1,2-N-acetylglucosaminyltransferase (POMGnT1), involved in the biosynthesis of mammalian type O-mannosyl glycans. Finally, we find that the POMGnT1 gene is responsible for muscle-eye-brain disease (MEB). MEB is an autosomal recessive disorder characterized by congenital muscular dystrophy, ocular abnormalities and brain malformation (type II lissencephaly). Like MEB, recent data suggest that the aberrant protein glycosylation of a specific glycoprotein, α-dystroglycan, is the primary cause of some forms of congenital muscular dystrophy. Here I review the new insight into glycobiology of muscular dystrophy and neuronal migration disorder.<br>

収録刊行物

  • 薬学雑誌

    薬学雑誌 123 (10), 825-835, 2003-10-01

    公益社団法人 日本薬学会

被引用文献 (2)*注記

もっと見る

参考文献 (69)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ